Recent advances in rheumatology
If you were to name the 3 most important recent advances in rheumatology that are relevant for everyday practice, what would they be?
If you were to name the 3 most important recent advances in rheumatology that are relevant for everyday practice, what would they be?
Dr Bhaskar Dasgupta from Southend University Hospital, UK, explains how to differentiate between myositis and noninflammatory myopathy and when to perform MRI and biopsy.
Dr Kim Legault from McMaster University presents the 3 most important recent advances in the management of SLE.
Dr Robert B. M. Landewé from the Amsterdam University Medical Center, The Netherlands, shares his views on the 3 most important recent advances in the management of spondyloarthritis.
Dr Daniel Aletaha shares his views on the 3 most important recent advances in the management of rheumatoid arthritis.
Dr Bhaskar Dasgupta from Southend University Hospital, UK, shares his views on the 3 most important recent advances in the management of systemic lupus erythematosus.
Is age a contraindication to the use of biologic drugs in patients with autoimmune diseases?
What do we know about the risk of cancer associated with biologic therapy?
There has been a growing number of cases of new-onset rheumatoid arthritis in older patients. What are the clues to suspect that joint pain may not be caused by osteoarthritis?
How can we differentiate between a flare of systemic lupus erythematosus (SLE) and an infection?